Fish & Richardson P.C

Embodiments of this specification provide an acquiring apparatus and a control method therefor. The acquiring apparatus includes a controller, a first NFC module, and a second NFC module. The first NFC module and the second NFC module work under control of the controller. The first NFC module is configured to work in a card reader mode, and is configured to transmit a first radio frequency signal, detect first response information, and obtain customer payment information from the first response information. The second NFC module is configured to work in a card emulation mode, and is configured to send second response information including merchant acquiring information in response to sensing a second radio frequency signal.

Provided herein are methods, kits, and systems, for simultaneous identification and quantification of an insertion site of a vector in a genome and copy number integration by hybridizing primers to a sample of genomic DNA and amplifying a series of extension products. The extension products can be further amplified and analyzed for a junction integration site and copy number of the inserted vector.

This disclosure pertains to pharmaceutical compositions of aerosolized compositions containing mitochondria, methods of preparing and using the compositions, and devices for administering the compositions.

A method implemented by a computer system for detecting personally identifiable information (PII) in clinical trial data before the clinical trial data is committed to a hardware storage device to improve data security, comprising: causing rendering of a graphical user interface for input of clinical trial data and one or more controls; receiving, through the graphical user interface, input clinical trial data; prior to committing the clinical trial data to a hardware storage device, associating, in memory, the clinical trial data associated with a pending state; upon determining that the clinical trial data does not include PII, accessing, from memory, the clinical trial data input into at least one of the one or more input portions; releasing the clinical trial data from the pending state; and committing the clinical trial data released to the hardware storage device.

This document relates to methods and materials involved in treating a mammal having a gastrointestinal disorder (e.g., an irritable bowel syndrome (IBS) such as post-infection IBS (PI-IBS)). For example, one or more protease inhibitors and/or one or more microorganisms that produce one or more protease inhibitors can be administered to a mammal having, or at risk of developing, a gastrointestinal disorder to treat the mammal.

Embodiments of this specification disclose methods, apparatuses, and computer systems for performing request conversion between resource management systems. The method includes: A first resource management system generates a first request packet in a first communication format. A first field in a packet header of the first request packet indicates that the first request packet is used to request an authorized freeze on a resource, and a packet body of the first request packet includes a number ID of a to-be-executed resource transfer operation and a first token. The first resource management system sends the first request packet to an interchange system in response to determining that the first token belongs to a predetermined type. The interchange system parses the first request packet, extracts the number ID and the first token from the first request packet, determines, by querying a first data record, a first account in a second resource management system corresponding to the first token, generates a second request packet in a second communication format based on an API specification of the second resource management system, and sends the second request packet to the second resource management system. The second request packet is used to call a target API, and a call parameter field of the second request packet includes the number ID and the first account. The second resource management system parses the second request packet based on the API specification, extracts the number ID and the first account from the call parameter field, and executes a target operation of a function corresponding to the target API on the first account.

This disclosure includes an ink composition that includes a polymer containing a polypyrrole and an organic solvent, in which the composition is a solution and the polymer is in an amount of from about 1 % to 70% by weight of the composition. This disclosure also relates to a printing process using such an ink composition and a product containing such an ink composition.

Provided herein are compounds of Formula (II) (e.g., Formula (II-a), (II-b), (II-a1), (II-b1), (II-a2), (II-b2), (II-3), (II-a3), (II-4), (II-a4), (II-5), (II-a5), (II-6), (II-a6), (II-7), (II-a7), (II-7), or (II-a8)), Formula (III) (e.g., Formula (III-1), (III-2), (III-3), (III-4), (III-5), (III-6), (III-7), or (III-8)), Formula (IV) (e.g., Formula (IV-a), (IV-b), (IV-c), (IV-a1), (IV-b1), (IV-a2), (IV-b2), (IV-a3), (IV-b3), (IV-a4), (IV-b4), (IV-a5), (IV-b5), (IV-a6), (IV-b6), (IV-a7), (IV-b7), (IV-a8), or (IV-b8)), Formula (V) (e.g., Formula (V-a) or (V-b), (V-a1), (V-c), (V-d), (V-b1), (V-a2), (V-b2), (V-a3), or (V-b3)), Formula (VI) (e.g., Formula (VI-a), (VI-b), (VI-c), (VI-d), or (VI-e))), or Formula (A) (e.g., Formula (I-a1)), or pharmaceutically acceptable salts thereof, that inhibit a KRas protein (e.g., a dysregulated KRas protein (e.g., a mutated or amplified KRas protein)). This disclosure also provides compositions containing the compounds as provided herein, or pharmaceutically acceptable salts thereof, as well as methods of using and making the same.

Methods, systems, and apparatus for executing, by a local processing device, a first instance of the application associated with a first user of the local processing device, receiving data output by a second instance executed by the remote processing device, the second instance of the application being associated with a second user of the local processing device, identifying a first synchronization point within the first instance, identifying a second synchronization point associated with the second instance, determining a temporal offset between the first instance and the second instance using the first synchronization point and the second synchronization point, and implementing one or more modifications to one or more of the first instance and the second instance to reduce the temporal offset.

A power converter controller with commands based on pulse pattern recognition is described. In one embodiment, a control system for a power converter includes a first switching circuit having a first controller, and a second switching circuit having a second controller. The second controller is configured to generate a pattern of pulses in a transmitted signal U<TX>. The pattern of pulses in the transmitted signal U<TX> corresponds to a predetermined command. The first controller is configured to receive a pattern of pulses in a received signal U<RX>. The first controller includes a pattern filter configured for: comparing the pattern of pulses in the received signal U<RX> with an expected pattern, and, when the pattern of pulses in the received signal U<RX> corresponds to the expected pattern, asserting the predetermined command.